Results 151 to 160 of about 84,296 (269)

Therapeutic Decisions in Inflammatory Bowel Disease: ChatGPT‐4.0 Compared to Medical Expertise

open access: yesJGH Open, Volume 10, Issue 4, April 2026.
ABSTRACT Introduction With the increasing prevalence of inflammatory bowel disease (IBD) and its complex management, evaluating innovative approaches became essential. Large language models (LLM), such as ChatGPT‐4.0, have remarkably advanced, yet their application in IBD management remains unexplored.
Helena Loncour   +3 more
wiley   +1 more source

Advances in Crohn's Disease: A Comprehensive Review of Pathophysiology, Diagnosis, and Emerging Therapeutics

open access: yesJGH Open, Volume 10, Issue 4, April 2026.
ABSTRACT Crohn's disease (CD) is a chronic inflammatory condition of the bowel with a rising global incidence. Its complex etiology involves genetic susceptibility, environmental factors, and alterations in the gut microbiota, leading to dysregulated immune responses.
Yoon‐Kyo An   +3 more
wiley   +1 more source

The Homeobox Genes: Classification, Regulation, Biological Functions, and Diseases

open access: yesMedComm, Volume 7, Issue 4, April 2026.
Overview of the homeobox gene superfamily and its pathophysiological roles. The homeobox superfamily comprises several major classes, including ANTP, PRD, TALE, LIM, POU, and others. Among these, the HOX clusters (A–D) play critical roles in embryonic development specifically in conferring cellular identity, regulating morphogenesis, and guiding axial ...
Maedeh Dadzadi   +5 more
wiley   +1 more source

Identification of Blood Pressure‐Associated Metabolites by Integrating Metabolomic and Genetic Analysis

open access: yesMedComm, Volume 7, Issue 4, April 2026.
This study identified 10 potential causality between metabolites and blood pressure and found potential genetic regulators of two metabolites. Multiomics integration revealed that a genetic variant near the omega‐3 metabolism genes (FADS1/FADS2) may influence blood pressure regulation by modulating prostaglandin E3 levels.
Yuanjiao Liu   +5 more
wiley   +1 more source

Lipid Metabolism and Obesity in Early Life: Drivers of Chronic Lung Disease From Development to Adulthood

open access: yesMolecular Nutrition &Food Research, Volume 70, Issue 7, 15 April 2026.
Metabolic and nutritional stressors are a growing global health concern. This review discusses how obesity, lipids, and lipid derivatives influence lung development, homeostasis, and chronic lung disease progression, highlighting roles of alveolar surfactant and sphingolipids.
Jaco Selle   +8 more
wiley   +1 more source

Immunocompromised Status Definition in Observational Studies Using Electronic Health Records: A Scoping Review and a Proposal for a Phenotype Identification Algorithm

open access: yesPharmacoepidemiology and Drug Safety, Volume 35, Issue 4, April 2026.
ABSTRACT Immunocompromised individuals experience an impaired immune function due to conditions that might be either congenital or acquired over the course of their lives. Epidemiological studies often rely on clinical definitions which, in some cases, benefit from being translated into machine‐readable algorithms for application to electronic health ...
Judit Riera‐Arnau   +62 more
wiley   +1 more source

The sphingosine-1-phosphate pathway is differentially activated in human gestational tissues. [PDF]

open access: yesJ Endocr Soc
Mbadhi MN   +6 more
europepmc   +1 more source

Targeting Sphingosine‐1‐Phosphate Signaling Attenuates Doxorubicin‐Aggravated Bone Loss in Obese Breast Cancer Mice

open access: yesSmart Medicine, Volume 5, Issue 2, April 2026.
During obese breast cancer‐bearing mice undergoing chemotherapy, DOX increases the concentration of S1P produced by breast cancer cells, which induces osteoclastogenesis through the activation of the S1PR1/p‐STAT3/NFATc‐1 pathway, thereby exacerbating bone loss in the breast cancer‐bearing mice with high‐fat dietary.
Yu Zhang   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy